Skip to main content
CNO
NYSE Finance

CNO Financial Reports Strong Q4 & Full-Year 2025 Results, Exceeding Guidance with 11% Operating EPS Growth

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$42.31
Mkt Cap
$4.034B
52W Low
$34.63
52W High
$44.19
Market data snapshot near publication time

summarizeSummary

CNO Financial Group announced strong Q4 and full-year 2025 financial results, exceeding all guidance metrics with significant operating EPS growth, record sales, and robust capital returns.


check_boxKey Events

  • Exceeded 2025 Guidance

    The company achieved, and in most cases exceeded, all its 2025 guidance metrics, demonstrating strong operational execution.

  • Operating EPS Growth

    Full-year 2025 net operating income per diluted share grew 11% to $4.40, with Q4 2025 operating EPS up 12% to $1.47.

  • Record Sales Momentum

    Total new annualized premiums (NAP) grew 15% for the full year, setting a new company record and marking the 14th consecutive quarter of strong insurance sales.

  • Significant Shareholder Returns

    The company repurchased $60 million of common stock in Q4 and $320 million for the full year, an 11% increase from 2024, reflecting healthy free cash flow generation.


auto_awesomeAnalysis

CNO Financial Group delivered a robust fourth quarter and full-year 2025 performance, surpassing all its 2025 guidance metrics. The company demonstrated consistent growth across key operational and financial indicators, including an 11% increase in full-year operating earnings per share and a 15% rise in total new annualized premiums. Strong capital management was evident through substantial share repurchases and an improved debt-to-capital ratio. These positive results, coupled with the stock trading near its 52-week high, suggest strong investor confidence and operational execution.

At the time of this filing, CNO was trading at $42.31 on NYSE in the Finance sector, with a market capitalization of approximately $4B. The 52-week trading range was $34.63 to $44.19. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CNO - Latest Insights

CNO
Mar 26, 2026, 4:13 PM EDT
Filing Type: DEF 14A
Importance Score:
7
CNO
Feb 24, 2026, 4:54 PM EST
Filing Type: 10-K
Importance Score:
7
CNO
Feb 05, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
8